Glioblastoma is a highly aggressive brain tumor with about a 10% 5-year survival rate. The debilitating disease affects roughly 3 people per 100,000. According to the Mayo Clinic Comprehensive Cancer ...

A £6.9m clinical trial programme that aims to improve brain cancer treatment for patients in Yorkshire has been launched by a ...

Targeted liposomal nanoparticles successfully cross the blood brain barrier to treat glioblastoma and doubled survival rates ...

GammaTile treatment reduces tumor recurrence or death risk by over 50% compared to standard care in operable brain metastases. More than half of GammaTile-treated patients were free from tumor ...

Childhood brain tumor survival depends on the type of tumor. Comparing survival rates across countries is difficult, because brain tumors aren't recorded in the same way everywhere in Europe. A new ...

A research team has discovered a previously overlooked subtype of brain tumor termed IME IDH-mutant astrocytoma. Contrary to typical medical expectations, this subtype exhibits strong immune activity, ...

MILAN and NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology, today announced that a total of 38 patients were enrolled in newly diagnosed ...

Childhood brain tumor survival depends on the type of tumor. Comparing survival rates across countries is difficult, because brain tumors aren’t recorded in the same way everywhere in Europe. A new ...